Taken together, these findings support the hypothesis that the increase of IL-22 production, potentially by intestinal ILC3, and the subsequent tissue response within the intestinal environment might be involved with the attenuation of hepatic steatosis that we observed in our study. The gene discussed is IL22; the disease is fatty liver disease.